Gene Therapy Company
Appears in 1 story
Conducting PIONEER trial of GS030 optogenetic therapy
Stanford researchers implanted a chip smaller than a Tic Tac under the retinas of 38 blind patients. A year later, 27 could read again. Some read entire books. The PRIMA device, published October 20, 2025 in the New England Journal of Medicine, is the first prosthetic to restore functional vision to people with macular degeneration—the leading cause of irreversible blindness.
Updated Jan 9
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
